The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

Innovative radiotherapy offers a precision treatment alternative.

Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

The big pharma company GlaxoSmithKline will inject up to $800 million into its manufacturing site in Marietta, Pennsylvania, ...

The expansion will involve the construction of a new buffer media facility and represents the largest investment from ...

A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% ...

Anu Codaty, VP of global marketing and strategy at Aldevron, is blazing trails in biotech, inspired by a family legacy in ...